Treatment for selective weight control
Patent 4525359 Issued on June 25, 1985. Estimated Expiration Date: 
December 10, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 10, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2493471 3074847 3422196 3808317 3818101 Cosmetic compositions having a slimming action Patent #: 4288433 InventorsApplicationNo. 06/448836 filed on 12/10/1982US Classes:514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/250, At least three rings in the polycyclo ring system514/263.34, Chalcogen bonded directly to the 2-and 6- positions of the purine ring system (e.g., theophylline, etc.)514/280Pentacyclo ring system having the six-membered hetero ring as one of the cyclosExaminersPrimary: Robinson, Douglas W.Attorney, Agent or FirmInternational ClassesA61K 47/00 (20060101)A61K 31/135 (20060101) A61K 31/41 (20060101) A61K 31/52 (20060101) A61K 31/519 (20060101) A61K 31/48 (20060101) A61K 31/475 (20060101) AbstractA treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.Other References
| |
